Dataset Information

Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors.

ABSTRACT: To identify BCATm inhibitors suitable for in vivo study, Encoded Library Technology (ELT) was used to affinity screen a 117 million member benzimidazole based DNA encoded library, which identified an inhibitor series with both biochemical and cellular activities. Subsequent SAR studies led to the discovery of a highly potent and selective compound, 1-(3-(5-bromothiophene-2-carboxamido)cyclohexyl)-N-methyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamide (8b) with much improved PK properties. X-ray structure revealed that 8b binds to the active site of BACTm in a unique mode via multiple H-bond and van der Waals interactions. After oral administration, 8b raised mouse blood levels of all three branched chain amino acids as a consequence of BCATm inhibition.

SUBMITTER: Deng H

PROVIDER: S-EPMC4834658 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors.

Deng Hongfeng H Zhou Jingye J Sundersingh Flora F Messer Jeffrey A JA Somers Donald O DO Ajakane Myriam M Arico-Muendel Christopher C CC Beljean Arthur A Belyanskaya Svetlana L SL Bingham Ryan R Blazensky Emily E Boullay Anne-Benedicte AB Boursier Eric E Chai Jing J Carter Paul P Chung Chun-Wa CW Daugan Alain A Ding Yun Y Herry Kenny K Hobbs Clare C Humphries Eric E Kollmann Christopher C Nguyen Van Loc VL Nicodeme Edwige E Smith Sarah E SE Dodic Nerina N Ancellin Nicolas N

ACS medicinal chemistry letters 20160208 4

To identify BCATm inhibitors suitable for in vivo study, Encoded Library Technology (ELT) was used to affinity screen a 117 million member benzimidazole based DNA encoded library, which identified an inhibitor series with both biochemical and cellular activities. Subsequent SAR studies led to the discovery of a highly potent and selective compound, 1-(3-(5-bromothiophene-2-carboxamido)cyclohexyl)-N-methyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamide (8b) with much improved PK properties. ...[more]

PMID: 27096045

Dataset Information

Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors.

Publications

Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

Discovery of 5-Aryl-2,4-diaminopyrimidine Compounds as Potent and Selective IRAK4 Inhibitors.
| S-EPMC9014513 | biostudies-literature

Discovery of Potent, Selective, and In Vivo Efficacious AKT Kinase Protein Degraders via Structure-Activity Relationship Studies.
| S-EPMC8900464 | biostudies-literature

Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of ?/?-hydrolase domain containing 6 (ABHD6).
| S-EPMC3987869 | biostudies-literature

Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist.
| S-EPMC4018059 | biostudies-literature

Discovery of Potent and Selective Antibody-Drug Conjugates with Eg5 Inhibitors through Linker and Payload Optimization.
| S-EPMC6912867 | biostudies-literature

Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.
| S-EPMC4025662 | biostudies-literature

Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics.
| S-EPMC2492884 | biostudies-literature

Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model.
| S-EPMC6862342 | biostudies-literature

Discovery of potent and selective covalent inhibitors of JNK.
| S-EPMC3270411 | biostudies-literature

Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors.
| S-EPMC8201751 | biostudies-literature